Top Markets
#1 Siacoin Siacoin +33.02%
#2 Official Trump Official Trump +23.94%
#3 EXOD EXOD +18.93%
#4 Wrapped STX (Velar) Wrapped STX (Velar) +18.60%
#5 MowCat MowCat +17.88%
#6 Melania Meme Melania Meme +17.83%
#7 Unit Pump Unit Pump +16.67%
#8 Pump.fun Pump.fun +16.67%
#9 Siren Siren +14.85%
#10 The Bitcoin Bull The Bitcoin Bull +14.83%
Coin of the day
Siacoin Siacoin
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Annovis Bio, Inc. Annovis Bio, Inc.

Annovis Bio, Inc.

ANVS
Rangering i aksjer #23205
Annovis Bio, Inc. is a clinical-stage biopharmaceutical company focused on... Annovis Bio, Inc. is a clinical-stage biopharmaceutical company focused on pioneering treatments for neurodegenerative disorders. The firm's flagship drug, Buntanetap, an oral medication, has successfully advanced through Phase 2a clinical trials for Alzheimer's and Parkinson's diseases. This compound is also currently being evaluated in clinical studies for Alzheimer's disease in individuals with Down Syndrome, as well as for various other chronic neurodegenerative conditions. Beyond Buntanetap, Annovis Bio is developing ANVS405 to offer protection against traumatic brain injury and stroke. Additionally, ANVS301 is progressing through Phase I clinical trials, aiming to enhance cognitive capabilities in the later stages of Alzheimer's disease and broader dementia. The company was founded in 2008 and operates out of Berwyn, Pennsylvania.
Aksjekurs
$1.81
Sist synkronisert: 2026-08-21
Markedsverdi
$77.00M
Endring (1 dag)
1.30%
Endring (1 år)
-23.63%
Land
US
Handel Annovis Bio, Inc. (ANVS)

Kategori

Healthcare
P/S-forhold for Annovis Bio, Inc. (ANVS)
P/S-forhold per 2026 TTM: 0
Ifølge Annovis Bio, Inc. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/S-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/S-forhold på 0.
P/S-historikk for Annovis Bio, Inc. fra 2026 til 2026
P/S-forhold ved hvert års slutt
År P/S-forhold Endre
Ikke nok data for de angitte datoene.
P/S-forhold for lignende selskaper eller konkurrenter
Selskap P/S-forhold Forskjell i P/S-forhold Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
11.28 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
2.95 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH